肝内胆管癌
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Diagnosis of liver nodules within and outside screening programs.
- Colombo M1.
- Annals of hepatology.Ann Hepatol.2015 May-Jun;14(3):304-9.
- Evaluation of a liver nodule detected with ultrasound includes the recovery of a detailed medical history, a physical exam, appropriate contrast imaging examinations and, in selected cases, histopathology. In this setting, identification of liver disease accompanying a liver nodule helps distinction
- PMID 25864209
- Retrospective and comparative study of inflammatory myofibroblastic tumor of the liver.
- Yang X1, Miao R, Yang H, Chi T, Jiang C, Wan X, Xu Y, Xu H, Du S, Lu X, Mao Y, Zhong S, Zhao H, Sang X.
- Journal of gastroenterology and hepatology.J Gastroenterol Hepatol.2015 May;30(5):885-90. doi: 10.1111/jgh.12846.
- BACKGROUND AND AIM: Inflammatory myofibroblastic tumor of the liver (IMTL) is a very rare benign disease with a good prognosis. The study aims to determine the clinical, radiological, and pathological characteristics of IMTL. The diagnosis and treatment strategies were discussed.METHODS: A total of
- PMID 25387431
- Proton beam therapy for unresectable intrahepatic cholangiocarcinoma.
- Ohkawa A1, Mizumoto M, Ishikawa H, Abei M, Fukuda K, Hashimoto T, Sakae T, Tsuboi K, Okumura T, Sakurai H.
- Journal of gastroenterology and hepatology.J Gastroenterol Hepatol.2015 May;30(5):957-63. doi: 10.1111/jgh.12843.
- BACKGROUND AND AIM: Treatment for unresectable intrahepatic cholangiocarcinoma (ICC) has not been established. The aim of the study was to evaluate the outcome of proton beam therapy (PBT) for patients with unresectable ICC.METHODS: Up to 2010, 20 patients (11 males, 9 females, median age 63 years o
- PMID 25376272
Japanese Journal
- 症例報告 肝動脈化学塞栓治療歴のある肉腫様変化を伴った肝内胆管癌の1例
- Intrahepatic cholangiocarcinoma: relationship between tumor imaging enhancement by measuring attenuation and clinicopathologic characteristics
- Nanashima Atsushi,Abo Takafumi,Murakami Goushi,Matsumoto Aya,Tou Kazuo,Takeshita Hiroaki,Kunizaki Masaki,Hidaka Shigekazu,Sakamoto Ichiro,Hayashi Hideyuki,Fukuda Toru,Kudo Takashi,Nagayasu Takeshi
- Abdominal Imaging 38(4), 785-792, 2013-08
- … Purpose: Arterial enhancement of intrahepatic cholangiocarcinoma (ICC) has been noted. …
- NAID 120005328276
- A Case of the Double Cancer Which Was Difficult to Distinguish Intrahepatic Cholangiocarcinoma From Multiple Hepatocellular Carcinomas
- 齋藤 宰,佐藤 秀一,[他]
- Shimane journal of medical science 29(2), 87-92, 2013-02-01
- NAID 110009591610
Related Links
- How does hepatitis C infection potentially put a patient at risk for intrahepatic cholangiocarcinoma? ... References Nakanuma Y, Curado MP, Franceschi S, et al. Intrahepatic cholangiocarcinoma. In: Bosman FT ...
- Intrahepatic cholangiocarcinoma (ICC) is an aggressive malignancy with very poor prognosis. Genome-wide, high-throughput technologies have made major advances in understanding the molecular basis of this disease, although ...
★リンクテーブル★
[★]
- 英
- intrahepatic bile duct cancer, intrahepatic cholangiocarcinoma
- 同
- 胆管細胞癌 cholangiocellular carcinoma CCC
- 関
- 肝癌、肝腫瘍
概念
- 原発性肝癌の約5%を占める
- 肝内胆管に由来する上皮性悪性腫瘍。
検査
- 単純CT:低吸収
- 造影CT:(動脈相)周辺がわずかに濃染、(平衡相以降)中心の線維性壊死が比較的高濃度、周辺部の腫瘍を含む領域は低吸収となる。(SRA.479)
- MRI:T2境界不明瞭な高信号、造影 ← 正常胆管はT1低信号、T2高信号(SRA.504)
- 腫瘍マーカー
- 早期癌には上昇しない
参考
- 1. 肝内胆管癌(胆管細胞癌) - こもんの日々つれづれ - Yahoo!ブログ
- 出典明記なく信頼度は不明
- http://blogs.yahoo.co.jp/comoson2000/43691821.html
- http://www.ncbi.nlm.nih.gov/books/NBK13176/
[★]